Back

KalVista Pharmaceuticals Stock Predictions

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Sell

KALV
KalVista Pharmaceuticals

Last Price:

10.21

Seasonality Move:

3.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.

KalVista Pharmaceuticals Stock Forecast

Over the next 52 weeks, KalVista Pharmaceuticals has on average historically risen by 10.2% based on the past 9 years of stock performance.
KalVista Pharmaceuticals has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Is KalVista Pharmaceuticals Stock Undervalued?
The current KalVista Pharmaceuticals [KALV] share price is $10.45. The Score for KALV is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
KALV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will KalVista Pharmaceuticals Stock Go Up Next Year?

Over the next 52 weeks, KalVista Pharmaceuticals has on average historically risen by 10.2% based on the past 9 years of stock performance.

KalVista Pharmaceuticals Stock Rating

Sell

KalVista Pharmaceuticals (KALV) is a Sell

Is KalVista Pharmaceuticals overpriced?

KalVista Pharmaceuticals has risen higher in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

KalVista Pharmaceuticals Stock Price History

Is KALV stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KALV is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

kalvista.com

52-Week Data

52-Week High:

16.88

52-Week Low:

7.39

Prediction Charts

Market Cap:

514.3M

Price in USD:

10.45

Volume:

314.04K

Beta:

1.26

Technical Analysis

SMA50:

11.33

SMA100:

12.20

SMA200:

12.34

52-Wk Change:

35.36%

Stock Predictions

Is KalVista Pharmaceuticals stock public?
Yes, KalVista Pharmaceuticals is a publicly traded company.
What is the KalVista Pharmaceuticals stock quote today?
The KalVista Pharmaceuticals stock price is 10.45 USD today.
How to buy KalVista Pharmaceuticals stock online?
You can buy KalVista Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Oct-25	12.16	11.68	12.23	11.68
Oct-28	11.77	12.09	12.34	11.77
Oct-29	12.05	11.77	12.15	11.63
Oct-30	11.66	11.20	11.81	11.17
Oct-31	11.16	10.28	11.42	10.01
Nov-1	10.29	10.61	10.72	10.22
Nov-4	11.30	11.63	12.85	10.92
Nov-5	11.45	11.25	11.68	10.78
Nov-6	12.00	11.40	12.12	11.21
Nov-7	11.35	11.18	11.58	11.02
Nov-8	11.18	11.41	11.41	10.94
Nov-11	11.38	11.09	11.62	10.88
Nov-12	11.11	10.67	11.22	10.58
Nov-13	10.75	10.45	10.97	10.44

KalVista Pharmaceuticals Earnings

KalVista Pharmaceuticals Earnings Report: Per Share KalVista Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.

KalVista Pharmaceuticals Forecast Revenue Growth

KalVista Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for KalVista Pharmaceuticals and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.07 per share.

* KalVista Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.